Washington University School of Medicine

Digital Commons@Becker
Independent Studies and Capstones

Program in Audiology and Communication
Sciences

2007

Role of synuclein proteins in auditory function
Catherine A. Young

Follow this and additional works at: https://digitalcommons.wustl.edu/pacs_capstones
Part of the Medicine and Health Sciences Commons

Recommended Citation
Young, Catherine A., "Role of synuclein proteins in auditory function" (2007). Independent Studies and
Capstones. Paper 518. Program in Audiology and Communication Sciences, Washington University
School of Medicine.
https://digitalcommons.wustl.edu/pacs_capstones/518

This Thesis is brought to you for free and open access by the Program in Audiology and Communication Sciences
at Digital Commons@Becker. It has been accepted for inclusion in Independent Studies and Capstones by an
authorized administrator of Digital Commons@Becker. For more information, please contact vanam@wustl.edu.

ROLE OF SYNUCLEIN PROTEINS IN AUDITORY FUNCTION
by
Catherine A. Young

An Independent Study Project
submitted in partial fulfillment of the
requirements for the degree of:
Masters of Science in Deaf Education

Washington University
Program of Audiology and Communication Sciences

May 18, 2007
Approved by:
Brian Faddis, Ph.D., Independent Study Advisor

Abstract: The recent discovery of synuclein proteins in peripheral auditory
tissues has prompted a closer examination of the role of these proteins in
hearing. In the present study, auditory brainstem response thresholds of
synuclein knockout mice are compared to wild type mice.
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Abstract
Alpha, beta and gamma-synuclein are small soluble proteins produced by three different
genes and are expressed primarily in the pre-synaptic terminals of neural tissues in certain
tumors. Although the normal function of these proteins is not definitively known, their recent
association with human neurodegenerative disorders has focused a great deal of interest on them.
In a recent pilot study to examine the localization of these proteins in rodent sensory systems, we
found synuclein isoforms in several auditory tissues, including spiral ganglion neurons, hair cells
and stria vascularis. To assess the functional role of these proteins in hearing, we examined
auditory brainstem response thresholds of mice with targeted deletions of alpha- and gammasynuclein proteins. Mice with targeted deletion of alpha-synuclein or both alpha- and gammasynuclein exhibited increased thresholds compared to wild type littermates at higher frequencies
tested. Data collected in this study could provide new information about the role of synuclein
proteins in the auditory system as well as other tissues.
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Role of Synuclein Proteins in Auditory Function
Introduction

Synuclein Proteins
Synuclein proteins are a family of small, heat-stable soluble proteins, found primarily in
neurons. There are three different types of synuclein proteins: alpha (α), beta (β), and gamma (γ)
(Clayton & George, 1998). The gene for α-synuclein is found on chromosome 4, the gene for βsynuclein is found on 5, and the gene for γ-synuclein proteins is found on chromosome 10
(Jellinger, 2003).
Synuclein proteins are composed of 120-140 amino acids, arranged in almost the same
repeating pattern for 93 residues. Mice and rats share identical synuclein composition for the
first 93 residues, and human synuclein proteins vary from these rodents only by two residues
(Clayton & George, 1998).
The first published description and terming of “synuclein” proteins occurred in 1988 by
Maroteaux et al. It was named as such due to findings of “synucleins” in both pre-synaptic
terminals and neuronal nuclear envelopes. This was the discovery of α -synuclein proteins.
Around this time, these proteins were discovered in multiple labs with many different names
being assigned. Within ten years following α -synuclein discovery, beta and gamma were also
characterized. (Clayton & George, 1998; Lavedan, 1998)

Localization
Alpha-, beta- and gamma-synucleins are localized in different areas within the central
and peripheral nervous systems. All three are found in high quantities in the human brain
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(Lavedan, 1998), although specific localization reports in the current literature are varied and
often contradictory.
Alpha-synuclein proteins are found primarily in the pre-synaptic terminals of developed
neurons throughout the central nervous system. During fetal development, at about 15-18 weeks
gestation, α-synucleins migrate from neuronal cell bodies to the terminals. (Norris et al., 2004)
The most concentrated areas with α-synucleins are the caudate nucleus, substantia nigra,
putamen and ventral pallidus, basil ganglion catecholaminergic regions in the midbrain. It is
important to note in particular that the substantia nigra is the production source of dopaminergic
neurons, and therefore the main source of Parkinson’s disease. Alpha-synucleins are also found
in high levels in the locus coerulus and vagus nuclei of the brainstem, and preganglionic
sympathetic nuclei and laminae I and II in the spinal cord (Li, Jensen & Dahlstrom, 2002).
Beta-synuclein proteins are found more uniformly throughout the brain, and in some
skeletal muscles. Similar to α-synuclein proteins, β-synucleins also originate at cell bodies and
relocate to pre-synaptic nerve terminals at 17-20 weeks gestation (Norris et al., 2004). Betasynucleins are located in somatic cholinergic regions—that is, around neurons that use the
neurotransmitter, acetylcholine. In particular, β-synucleins occupy the nuclei of cranial nerves,
including the oculomotor, facial, hypoglossal, accessory and ambiguous (Li, Jensen &
Dahlstrom, 2002).
The gamma synuclein protein is localized primarily in the cytosol of neurons in the
peripheral nervous system and in epidermis, although it is also found in the brain and spinal cord.
(Norris et al., 2004) Gamma-synucleins reside in both cholinergic and catecholaminergic
regions. Notable locations of high concentration of γ-synuclein are the locus coeruleus in the
brainstem, the terminals and soma of Edinger-Westphal nuclei (of the oculomotor nerve), and the
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nuclei of most cranial nerves. In the spinal cord, like α-synuclein, γ-synuclein proteins are found
in laminae I and II as well as preganglionic sympathetic nuclei (Li, Jensen & Dahlstrom, 2002).
In mammals and birds, α- and β-synuclein proteins are found in highest concentration in
the hippocampus, cortex, olifactory bulb and nuclei—areas of the brain where continual synaptic
modification occurs (Clayton & George, 1998).

Suggested Roles in Normal Physiology
Little is known definitively about the cellular functions of synuclein proteins. Beta and
γ-synucleins in particular are yet to be understood. Beta-synuclein proteins may help to balance
α-synucleins and block them from accumulating (Adamczyk, Solecka & Strosznajder, 2005). In
general, γ-synucleins often serve the same functions as α- and β-, only to a lesser extent (Quilty
et al., 2003). Uniquely, γ-synuclein proteins may be involved in cytoskeletal preservation
(Norris et al., 2004).
Many conclusions about the role of synucleins are made based on their localization. As
previously stated, both α- and β-synuclein are present in neuronal pre-synaptic terminals; this in
itself provides information about potential physiology. George et al. (1995) studied the role of
synucleins in the song development of songbirds. During the month-long period of their critical
development, synuclein proteins are abundant in song control nucleus (IMAN) terminals, after
which time the quantity of synucleins decreases significantly. This study supports the belief that
α- and β-synuclein proteins are important for neuronal plasticity, as the proteins are only present
while terminals restructure and new synaptic connections are made (Clayton & George, 1998).
The most information on synucleins is derived from α-synuclein proteins. There are
many proposed functions of α-synuclein proteins. The amino acid structural patterns of α-
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synuclein proteins allow for versatility in its formation based on an influential environment
(Sidhu et al., 2004).
One role of synuclein proteins is that of a regenerator. Duda et al (1999) studied cells
within the olfactory system and asserted that α-synucleins were involved in the constant
regeneration of epithelial basal cells and receptor neurons (Norris et al., 2004). Both α- and βsynuclein (and γ- to a lesser extent) were found to gather around neuronal terminals that have
been damaged (Quilty et al., 2003).
A second proposed role is that of a synaptic regulator. Alpha-synucleins maintain
synaptic flow by regulating the passage of vesicles in neuronal pre-synaptic terminals. Cabin et
al (2002) examined α-synuclein knockout mice and found problematic synaptic transmission was
occurring; both docked and distal vesicles were weakened with over-stimulation (Norris et al.,
2004). Cabin et al. (2002) also found in α-synuclein knockout mice that, relative to wild-type
littermates, there were decreased levels of synapsin, a protein which regulates synaptic
neurotransmitter release. This implies that synucleins are essential for synaptic maintenance and
vesicle recycling (Sidhu et al., 2004). Alpha-synuclein proteins also help to maintain
homeostasis and plasticity in neuronal synapses. Specifically, α-synuclein proteins help to
maintain the homeostasis of dopamine levels; should this role fail to be fulfilled due to mutation,
neurodegeneration could occur, as we will discuss in the following section (Sidhu et al., 2004).
Alpha-synucleins may also act as a protector. In fact, through the interaction with αsynucleins, apoptotic proteins are reduced in activity and expression. Jensen et al. found that αsynuclein proteins directly protect mitochondria by blocking MPP+ and rotenone, neurotoxins
that inhibit dopaminergic and mitochondreal function and contribute to Parkinson’s. However,
this blocking protection by synucleins does not occur for all cells, as seen with differentiated
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dopaminergic neurons. This could mean that the protective capability of synucleins is dependent
upon level of cell differentiation, or perhaps this ability changes with age (Sidhu et al., 2004).
Kholodilov et al. (1999) also induced apoptosis with dopaminergic neurons, and found αsynuclein expressed specifically in surviving, protected neurons, rather than those that do not
survive (Sidhu et al., 2004).
A final role of α-synucleins is that of a molecular chaperone. Ostrerova et al (1999)
showed that α-synuclein and chaperone protein 14-3-3 share similar sequencing and may also
bind together and serve similar protein-folding functions. Souza et al (2000) determined that all
three types of synucleins could serve as molecular chaperones if they were without mutation
(Norris et al., 2004). At the end of α-synucleins is an acidic carboxyl-terminal, made of
glutamate and aspartate residues, which help with the ability to serve as a chaperone (Sidhu et
al., 2004).

Synuclein Pathology
There are a number of ways in which synuclein proteins can become pathological. These
include: aggregation due to mutation of the proteins, oxidative stress, over-expression of
synuclein proteins and possibly aging (Volles & Lansbury, 2007; Norris et al., 2004; Adamczyk,
Solecka & Strosznajder, 2005; Kaplan, Ratner & Haas, 2003). However, Xu et al. (2002) stated
that over-expression does not always lead to pathology. They found that, while over-expression
of α-synuclein is toxic for dopaminergic neurons, it might serve as a protectant to other types of
neurons.
Uniquely, γ-synucleins have been linked to breast cancer. That is, γ-synucleins are
present in much greater quantities in advanced stages of breast cancer tissue than in non-
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cancerous breast tissues. It is thought, therefore, that they may contribute to cancer progression
(Norris et al., 2004).
Three known α-synuclein mutations have been linked to familial Parkinson’s disease.
These protein mutations are called A30P, A53T and E46K. The α-synuclein mutation, A30P,
hinders membrane binding, A53T may cause apoptosis of dopaminergic neurons (Kaplan, Ratner
& Haas, 2003) and E46K may lead to more aggregates than the other two mutants (Pandey,
Schmidt & Galvin, 2006).
Because they are believed to play important roles in neuronal regulation and protection,
mutations of synucleins will naturally have disastrous effects. The term “Synucleinopathies”
describes neurodegenerative disorders involving aggregates of α-synuclein abnormalities. The
proteins accumulate or are misfolded, become unsoluable and can form Lewy bodies, the
histological hallmark of Parkinson’s disease, Down’s syndrome, Alzheimer’s disease and other
cytoplasmic inclusions (Jellinger, 2003). The link between Parkinson’s and α-synuclein proteins
has been a highly discussed topic for the last several years, following the discovery of the
causative mutations mentioned above.
Braak et al. (2003) found that synuclein pathology sometimes originates toward the back
of the brainstem, then moves to limbic system and other regions within the cortex, and years later
to the substantia nigra of the midbrain. Because α-synucleins have been found to regulate the
amount of dopamine made, mutation greatly disrupts regulation. Down’s syndrome and
Alzheimer’s disease are commonly developed due to α-synuclein aggregates within the
amygdala of the limbic system (Galvin, 2006).
Aging has been found to be another possible cause of synuclein pathology. There are
significant changes in α-synuclein localization that occur in the brain due to aging. Namely,
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immunoreactivity and expression of α-synuclein proteins in the cerebellum significantly reduces
with age. In addition, immunoreactivity in the cortex and hippocampus significantly reduced in
aged rats, yet expression of the gene was unaffected in these regions. There was also more
oxidative stress present. The mobility of α-synuclein proteins through axons became
significantly slower in aged rats. This slowed transmission makes synucleins more vulnerable to
mutation and aggregation. There was not an significant aging effect noted for β-synuclein
proteins. (Adamczyk, Solecka & Strosznajder, 2005).

Localization in Sensory Systems
Recent discoveries by Surgucheva, Faddis and Surguchov (2007) have indicated that
synuclein proteins are also localized within both the visual and auditory systems.
Gamma-synuclein were discovered to be abundant in the lens of rat embryos, with the
quantity decreasing over the course of 42 days. In addition, γ-synucleins are localized in cells of
the cornea, retina, and in photoreceptors.
Within the cochlea of the auditory system, both α- and β-synuclein proteins were found in
hair cells. Large amounts of γ-synucleins were found specifically in outer hair cells and βsynuclein proteins were found in spiral ganglion cells. Synucleins were also discovered in the
stria vascularis (Surgucheva et al., personal communication).

Present Study
The known presence of synuclein proteins within the auditory system led to the
investigation of the role they play within the auditory system. Are synucleins essential for the
maintenance and protection of cells within the auditory system, as they are in many parts of the
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brain? Using transgenic mice, the current study examined if the absence of the gene producing
synuclein proteins influenced hearing sensitivity of mice.

Materials & Methods
Animals
Thirty-two juvenile mice (eight-weeks of age) were used in the present study. There
were six genotyped with a knockout of the α-synuclein-producing gene, and seven γ-synuclein
protein knockout mice. There were twelve double-knockout mice, lacking the gene for both αand γ-synuclein proteins. The control group was comprised of six wild-type mice. Both the
synuclein knockout and the wild type mice were taken from the same litters.
Male: female breeding pairs that were both heterozygous for a specific deleted synuclein
gene were used to produce litters of mixed genotypes. By breeding in this manner, both true
knockouts and wild type mice could be pulled from the same litters to help avoid differences due
to genetic and environmental influences. However, too few such pairs were actually available to
perform this type of comparison. ABR thresholds were also conducted on some heterozygous
littermates but the heterozygous genotypes were not included in the statistical analysis due to the
small sample size. Animal cages were stored in an approved facility at Washington University,
and were kept on a 12/12-light/dark cycle. Food and water were available on an ad-lib basis.

Methods
Auditory Brainstem Response (ABR) Recordings were collected once for each mouse, using
the right ear. Using an anesthetic solution (80mg/kg ketamine, 15 mg/kg zylazine, IP), the
animals were sedated at least ten minutes prior to performing ABR recordings.
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In a sound-proof booth, the animals were placed on a thermostatically-controlled heating pad
that, in conjunction with a rectal probe (Yellow Springs Instruments Model 73A), regulated their
temperature at 37.5 ±1 °C. Three platinum needle electrodes (Grass) were inserted in the
animals; the active probe was inserted vertically behind the ear, the reference was inserted
horizontally in the coronal plane between the eyes, and the ground was inserted horizontally in
the back. The electrodes were hooked up to a Grass P15 differential amplifier (100-10,000 Hz,
x100), which led to a custom amplifier that provided an additional gain of x1,000. A Cambridge
Electronic Design µ1401 and SIGNAL™ and custom signal averaging software on a 120MHz
Pentium PC digitized the information at 30kHz and were used to conduct and analyze the
recordings.
A Wavetek Model 148 oscillator produced the sine wave stimuli, and a custom electronic
switch shaped it to 5ms total duration, with 1ms rise/fall times. A Crown D150A power
amplifier amplified the stimulus. The amplified tone burst signal was presented 1,000 times at
20 signals per second, using a KSN1020A piezo ceramic speaker, placed 10 cm laterally away
from the rodent’s patent right pinna. Evoked threshold measures were recorded at 5, 10, 20, 28.3
and 40 kHz, using increments no less than 5dB. Calibration was done with a B&K 4135 ¼ inch
microphone at the aforementioned distance from the speaker.

Data Analysis
To investigate the possible auditory function of synuclein-proteins, as measured by
Auditory Brainstem Response thresholds, a two-way Analysis of Variance (ANOVA) was across
frequency and genotype—wild type, α-synuclein knockout, γ-synuclein knockout, and double
knockout. To test the level of deletion possibly needed to influence hearing function, the
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Auditory Brainstem Response thresholds of heterozygous littermates were also taken and
analyzed.

Results
There was no obvious phenotype—physical or behavioral—observed in the transgenic
mice due to deletion of the γ-or α-synuclein gene relative to wild type littermates.
A Two-Way Repeated Measures ANOVA (one factor repetition) revealed a significant
main interaction between genotype and frequency, F (12) =2.19, p=0.017. A Holm-Sidak
method analysis revealed a highly significant effect of genotype at 40 kHz when comparing αsynuclein knockout with wild type mice (p=0.000) (See Figure 1). There was also a significant
effect of genotype found at 40 kHz when comparing double-knockout mice with wild type mice
(p=0.022) (See Figure 3). Heterozygous mice did not significantly differ from wild type.
In completing post mortem histological examinations on the mice tested in the study, it
was found that the general cochlear architecture was sound, but there was a possible reduction of
spiral ganglion cell density in the base of the cochlea.

Discussion
Results of this study demonstrate a high frequency (40 kHz) hearing loss due to the
deletion of the α-synuclein protein gene. Double knockout mice, lacking both alpha and gammasynuclein proteins, were also found to have significantly elevated threshold at 40 k Hz. Gamma
synuclein knockout mice did not demonstrate an increased threshold. Presumably the double
knockout effect represents a functional deficit caused by the absent α-synuclein protein. It was
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also found that the effect of the different genotypes is dependent upon the frequency tested—the
interaction was statistically significant.
The present study is the first to demonstrate a sensory function and deficit associated with
synuclein proteins. In previous investigations, even dopaminergic systems showed no deficits
with the deletion of synuclein proteins; rather, deficits occurred due to synuclein mutation or
over-expression. Results of this study revealed that the absence of synuclein proteins does have
negative effects on hearing sensitivity, and therefore that synuclein proteins do play some role in
auditory function.
In light of synuclein localization in the cochlea and significantly elevated high-frequency
thresholds, there are a few roles that synuclein proteins could play in the auditory system. As
previously stated, one of their main proposed functions in neurons is synaptic regulation and
regeneration and vesicle transmission; therefore, synucleins are likely involved in synaptic
activity in the auditory system as well. Synuclein proteins could also play a role in outer-hair
cell motility.
One shortcoming of this experiment was the small sample size. It is likely that with a much
larger test population, elevated thresholds of transgenic synuclein knockout mice would appear
over more frequencies. Further histological exploration should take place with this larger sample
size to understand the effect of the gene deletion on auditory structures with greater specificity.
Because there is believed to be a decline in synuclein expression with age (Adamczyk,
Solecka & Strosznajder, 2005), another future study could investigate a possible connection
between synuclein proteins and age-related hearing loss. In addition, due to the protective role
of synucleins, a future study could test the outcome of noise exposure on mice with a synuclein
gene deletion.

12

Young
References
Adamczyk, A. & Strosznajder, J. (2006). Alpha-synuclein potentiaties Ca2+ influex through
voltage-dependent Ca2+ channels. Neuroreport, 17(18), 1883-1886.
Adamczyk, A., Strosznajder, J. & Solecka, J. (2005). Expression of α-synuclein in different brain
parts of adult and aged rats. Journal of Physiology and Pharmacology, 56(1), 29-37.
Clayton, D., George, J. (1998). The synucleins: a family of proteins involved in synaptic
function, plasticity, neurodegeneration and disease. Trends in Neuroscience, 21(6), 249
254.
Fan, Y., Limprasert, P., Murray, I., Smith, A., Lee, V. Trojanowski, J., Sopher, B., La Spada, A.
(2006). Β-synuclein modulates α-synuclein protein expression. Human Molecular
Genetics, 15(20), 3002-3011.
Galvin, J. (2006). Interaction of alpha-synuclein and dopamine metabolites in the pathogenesis
of Parkinson’s disease: a case for the selective vulnerability of the substantia nigra. Acta
Neuropathologica, 112 (2), 115-126.
Giasson, B. & Duda, J. (2000). Oxidative damage linked to neurodegeneration by selective
alpha-synuclein nitration in synucleinopathy lesions. Science, 290(5493), 985-9.
Jellinger, K. (2003). Neuropathological spectrum of synucleinopathies. Movement Disorders,
18(6), S2-S12.
Kamp, F. & Beyer, K. (2006). Binding of α-synuclein affects the lipid packing in bilayers of
small vesicles. Journal of Biological Chemistry, 281(14), 9251-9259.
Kaplan, B., Ratner, V., & Haas, E. (2003). Alpha-synuclein: it’s biological function and role in
neurodegenerative diseases. Journal of Molecular Neuroscience, 20, 83-92.
Lavedan, C. (1998). The synuclein family. Genome Research, 8, 871-880.

13

Young
Li, J., Jensen, P., Dahlstrom, A. (2002) Differential Localization of α-, β-, and γ-synucleins in the
rat cns. Neuroscience, 113(2), 463-478.
Norris, E., Giasson, B., & M. -Y. Lee. (2004). Alpha-Synuclein: normal function and role in
neurodegenerative diseases. Current Topics in Developmental Biology,60, 17-54.
Pandey, N., Schmidt, R.E., & Galvin, J.E. (2006). The alpha-synuclein mutation E46K promotes
aggregation in cultured cells. Experimental Neuroscience, 197 (2), 515-520.
Park, S. et al. (2002). Evidence that α-synuclein functions as a negative regulator of Ca++dependent α-granule release from human platelets. Blood, 100(7), 2506-2514.
Quilty, M., Gai, W., Pountney, D., West, A., Vickers, J. (2003). Localization of α-, β-, and γ
synuclein during neuronal development and alterations associated with the neuronal
response to axonal trauma. Experimental Neurology, 182, 195-207.
Saha, A., Ninkina, N., Hanger, D., Anderton, B. Davies, A., & Buchman, V. (2000). Short
communication: induction of neuronal death by alpha-synuclein. European Journal of
Neuroscience, 12, 3073-7.
Sidhu, A., Wersinger, C., Moussa, C. & Vernier, P. (2004). The role of α-synuclein in both
neuroprotection and neurodegeneration. Annals of the New York Academy of Sciences,
1035, 250-270.
Snyder, H. et al. (2004). β-synuclein reduces proteasomal inhibition by α-synuclein but not γsynuclein. The Journal of Biological Chemistry, 280(9), 7562-7569.
Surgucheva, I., Faddis, B., & Surguchov, A. (2007). Synucleins in sensory systems: localization,
and developmental changes. In preparation.
Totterdell, S. & Meredith, G. (2005). Localization of alpha-synuclein to identified fibers and
synapses in the normal mouse brain. Neuroscience, 135, 907-913.

14

Young
Volles, M. & Landsbury Jr., P. (2007). Relationships between the sequence of α-synuclein and
its membrane affinity, fibrillization propensity, and yeast toxicity. Journal of Molecular
Biology, 366, 1510-1522.
Xu, J., Kao, S., Lee, F., Song, W., Jin, L. & Yankner, B. (2002). Dopamine-dependent
neurotoxicity of α–synuclein: a mechanism for selective neurodegeneration in
parkinson’s disease. Nature Medicine, 8(6), 600-6.

15

Young
Figure Legend

Figure 1. Auditory Brainstem Response Thresholds Of Alpha-Synuclein Knockout
Mice. This is a line graph of the ABR thresholds for α-synuclein KO mice and their wildtype counterparts. On the x-axis is frequency in kHz and the y-axis is ABR thresholds in dB.
The solid black line represents the wild-type mice and the green dotted lines represent the αKO mice. The red dotted line indicates the heterozygous data, used for comparison. In this
graph, you can see that the thresholds of α-knockout mice are consistently above the wild
type, although it is only a significantly elevated threshold at 40kHz.

Figure 2: Auditory Brainstem Response Thresholds of Gamma-Synuclein Knockout
Mice. This is a line graph of the ABR thresholds for γ-synuclein KO mice and their wildtype counterparts. On the x-axis is frequency in kHz and the y-axis is ABR thresholds in dB.
The solid black line represents the wild-type mice and the green dotted lines represent the γKO mice. The red dotted line indicates the heterozygous data, used for comparison. The
graph suggests that there is a difference in γ-KO thresholds, but a two-way ANOVA
indicates that this difference is not significant.
Figure 3: Auditory Brainstem Response Thresholds of Alpha/Gamma-Synuclein
Double Knockout Mice. This is a graph of the ABR thresholds for α- and γ-synuclein
double KO mice and their wild type littermates. At 40kHz, there is a significant effect of
genotype compared to the wild-type mice. The significant threshold elevation seen on this
graph is thought to be an effect of the deletion of α-synuclein rather than γ, since γ-synuclein
single knockout mice were not found to have significant threshold differences.
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Figure 1

Auditory Brainstem Response Thresholds
Of Alpha-Synuclein Knockout Mice
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Figure 2

Auditory Brainstem Response Thresholds
of Gamma-Synuclein Knockout Mice
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Figure 3

Auditory Brainstem Response Thresholds
of Alpha/Gamma-Synuclein Double Knockout Mice
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